{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T07:55:56Z","timestamp":1792742156979,"version":"4.5.0"},"reference-count":34,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2026,5,8]],"date-time":"2026-05-08T00:00:00Z","timestamp":1778198400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Endocrinol."],"abstract":"<jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>The triglyceride\u2013glucose (TyG) index is widely recognized as a surrogate marker of insulin resistance and reflects disturbances in glucose and lipid metabolism. Although higher TyG index levels have been associated with hypertension, the factors related to this association remain incompletely understood. This study aimed to examine the association between the TyG index and hypertension and to explore whether fatty liver might statistically account for part of this association.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>This cross-sectional study included participants who underwent routine health examinations at the Third Affiliated Hospital of Wenzhou Medical University between 2021 and 2025. For individuals with multiple examination records during the study period, only the first record was retained for analysis. The TyG index was calculated using fasting triglyceride and glucose levels. Fatty liver was assessed by abdominal ultrasonography, and hypertension was defined according to the 2023 European Society of Hypertension guidelines. Multivariable logistic regression models were used to evaluate the associations of the TyG index with hypertension and fatty liver. Mediation analysis was performed to explore whether fatty liver might account for part of the observed association between the TyG index and hypertension.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>A total of 115,327 participants were included in the final analysis. The TyG index was significantly associated with hypertension. Each 1-unit increase in the TyG index was associated with higher odds of hypertension (adjusted OR\u00a0=\u00a02.09, 95% CI: 2.03\u20132.15). The TyG index was also strongly associated with fatty liver (adjusted OR\u00a0=\u00a07.05, 95% CI: 6.82\u20137.28). Mediation analysis suggested that fatty liver might account for part of the observed association between the TyG index and hypertension, with a proportion statistically accounted for of 23.50% (95% CI: 21.39%\u201325.96%).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>In this health examination population, a higher TyG index was significantly associated with hypertension, and fatty liver may account for part of the observed association. Further longitudinal studies are needed to clarify these findings.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.3389\/fendo.2026.1826006","type":"journal-article","created":{"date-parts":[[2026,5,8]],"date-time":"2026-05-08T04:43:22Z","timestamp":1778215402000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":1,"title":["Association between the triglyceride\u2013glucose index and hypertension: potential role of fatty liver in a cross-sectional study"],"prefix":"10.3389","volume":"17","author":[{"given":"Yuzhan","family":"Lin","sequence":"first","affiliation":[{"name":"Department of Clinical Laboratory, The Third Affiliated Hospital of Wenzhou Medical University","place":["Ruian, Zhejiang, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ruixue","family":"Sun","sequence":"additional","affiliation":[{"name":"Department of Clinical Laboratory, The Third Affiliated Hospital of Wenzhou Medical University","place":["Ruian, Zhejiang, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lifeng","family":"Wu","sequence":"additional","affiliation":[{"name":"Department of Clinical Laboratory, The Third Affiliated Hospital of Wenzhou Medical University","place":["Ruian, Zhejiang, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lei","family":"Chen","sequence":"additional","affiliation":[{"name":"Department of Clinical Laboratory, The Third Affiliated Hospital of Wenzhou Medical University","place":["Ruian, Zhejiang, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chen","family":"Fu","sequence":"additional","affiliation":[{"name":"Department of Clinical Laboratory, Ruian Traditional Chinese Medicine Hospital","place":["Ruian, Zhejiang, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shaorong","family":"Yan","sequence":"additional","affiliation":[{"name":"Department of Clinical Laboratory, The Third Affiliated Hospital of Wenzhou Medical University","place":["Ruian, Zhejiang, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jianze","family":"Cai","sequence":"additional","affiliation":[{"name":"Hospital Infection Management Department (Public Health Department), The Third Affiliated Hospital of Wenzhou Medical University","place":["Ruian, Zhejiang, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2026,5,8]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","DOI":"10.1007\/s12170-024-00750-9","article-title":"Hypertension management to reduce racial\/ethnic disparities: Clinical and community-based interventions","volume":"18","author":"Turkson-Ocran","year":"2024","journal-title":"Curr Cardiovasc Risk Rep"},{"key":"B2","doi-asserted-by":"publisher","DOI":"10.1590\/1413-812320253012.06232024","article-title":"Prevalence of chronic diseases and factors associated with multimorbidity in the Brazilian Amazon: a cross-sectional population-based study, 2019","volume":"30","author":"Tiguman","year":"2024","journal-title":"Cien Saude Colet"},{"key":"B3","doi-asserted-by":"publisher","DOI":"10.1590\/1413-81232025309.11922023","article-title":"Health care utilization after COVID-19 in persons with non-communicable diseases in Rio Grande, Rio Grande do Sul, Brazil","volume":"30","author":"Vieira","year":"2024","journal-title":"Cien Saude Colet"},{"key":"B4","doi-asserted-by":"publisher","DOI":"10.3389\/fnut.2024.1515918","article-title":"Triglyceride-glucose index as a marker for visceral obesity in patients with gastric cancer","volume":"11","author":"Zuo","year":"2025","journal-title":"Front Nutr"},{"key":"B5","doi-asserted-by":"publisher","DOI":"10.3389\/fendo.2024.1431087","article-title":"Triglyceride-glucose index as a mediator of body mass index and cardiovascular disease in middle-aged and older Chinese adults: a nationally representative longitudinal cohort study","volume":"15","author":"Gan","year":"2024","journal-title":"Front Endocrinol (Lausanne)"},{"key":"B6","doi-asserted-by":"publisher","first-page":"1237","DOI":"10.3390\/ijms21113863","article-title":"The role of insulin resistance and diabetes in nonalcoholic fatty liver disease","volume":"21","author":"Fujii","year":"2020","journal-title":"Int J Mol Sci"},{"key":"B7","doi-asserted-by":"publisher","DOI":"10.3389\/fendo.2024.1499120","article-title":"Correlations of the triglyceride-glucose index and modified indices with arterial stiffness in overweight or obese adults","volume":"15","author":"Tang","year":"2024","journal-title":"Front Endocrinol (Lausanne)"},{"key":"B8","doi-asserted-by":"publisher","first-page":"168","DOI":"10.1186\/s12872-024-03747-9","article-title":"Association between triglyceride-glucose index and hypertension: a cohort study based on the China Health and Nutrition Survey (2009-2015)","volume":"24","author":"Wang","year":"2024","journal-title":"BMC Cardiovasc Disord"},{"key":"B9","doi-asserted-by":"publisher","DOI":"10.1016\/j.numecd.2024.05.014","article-title":"Long-term burden and increasing trends of body mass index are linked with adult hypertension through triglyceride-glucose index: A 30-year prospective cohort study","volume":"34","author":"Liao","year":"2024","journal-title":"Nutr Metab Cardiovasc Dis"},{"key":"B10","doi-asserted-by":"publisher","DOI":"10.3389\/fendo.2025.1636890","article-title":"Sex-specific associations between the triglyceride-glucose index and new-onset hypertension in a hospital employee cohort: evidence from longitudinal annual health examinations","volume":"16","author":"Sun","year":"2025","journal-title":"Front Endocrinol (Lausanne)"},{"key":"B11","doi-asserted-by":"publisher","DOI":"10.3389\/fcvm.2024.1473171","article-title":"Sex-specific differences in the association between triglyceride glucose index and carotid plaque in a cardiovascular high-risk population: a cross-sectional study based on a Chinese community-dwelling population","volume":"11","author":"Lin","year":"2024","journal-title":"Front Cardiovasc Med"},{"key":"B12","doi-asserted-by":"publisher","DOI":"10.3389\/fendo.2025.1478640","article-title":"Sex-specific differences in the relationship between fasting plasma glucose and carotid plaque in a cardiovascular high-risk population: a cross-sectional study","volume":"16","author":"Xu","year":"2025","journal-title":"Front Endocrinol (Lausanne)"},{"key":"B13","doi-asserted-by":"publisher","DOI":"10.3389\/fpubh.2024.1320918","article-title":"The effect of insulin resistance in the association between obesity and hypertension incidence among Chinese middle-aged and older adults: data from China health and retirement longitudinal study (CHARLS)","volume":"12","author":"Niu","year":"2024","journal-title":"Front Public Health"},{"key":"B14","doi-asserted-by":"publisher","first-page":"243","DOI":"10.1186\/s12933-024-02334-8","article-title":"Metabolic score for insulin resistance (METS-IR) predicts all-cause and cardiovascular mortality in the general population: evidence from NHANES 2001-2018","volume":"23","author":"Duan","year":"2024","journal-title":"Cardiovasc Diabetol"},{"key":"B15","doi-asserted-by":"publisher","first-page":"1874","DOI":"10.1097\/HJH.0000000000003480","article-title":"2023 ESH guidelines for the management of arterial hypertension the task force for the management of arterial hypertension of the European Society of Hypertension: Endorsed by the International Society of Hypertension (ISH) and the European Renal Association (ERA)","volume":"41","author":"Mancia","year":"2023","journal-title":"J Hypertens"},{"key":"B16","doi-asserted-by":"publisher","DOI":"10.1007\/s00125-016-3902-y","article-title":"Clinical practice guidelines for the management of non-alcoholic fatty liver disease","volume":"59","year":"2016","journal-title":"Diabetologia"},{"key":"B17","doi-asserted-by":"publisher","DOI":"10.1037\/a0020761","article-title":"A general approach to causal mediation analysis","volume":"15","author":"Imai","year":"2010","journal-title":"Psychol Methods"},{"key":"B18","doi-asserted-by":"publisher","first-page":"590","DOI":"10.3390\/biomedicines13030590","article-title":"From metabolic syndrome to cardio-kidney-metabolic syndrome in the SIMETAP study: Prevalence rates of metabolic syndrome and its independent associations with cardio-renal-metabolic disorders other than its defining criteria","volume":"13","author":"Ruiz-Garc\u00eda","year":"2025","journal-title":"Biomedicines"},{"key":"B19","doi-asserted-by":"publisher","DOI":"10.2147\/DMSO.S535535","article-title":"Prediction of hypertension risk in patients with fatty liver disease using the triglyceride-glucose-body mass index","volume":"18","author":"Gao","year":"2025","journal-title":"Diabetes Metab Syndr Obes"},{"key":"B20","doi-asserted-by":"publisher","first-page":"15695","DOI":"10.1038\/s41598-025-01003-4","article-title":"Association of cardiometabolic markers with hepatic steatosis and liver fibrosis in population without obesity and diabetes","volume":"15","author":"Fan","year":"2025","journal-title":"Sci Rep"},{"key":"B21","doi-asserted-by":"publisher","first-page":"310","DOI":"10.1186\/s12933-024-02392-y","article-title":"Diagnostic and prognostic value of triglyceride glucose index: a comprehensive evaluation of meta-analysis","volume":"23","author":"Nayak","year":"2024","journal-title":"Cardiovasc Diabetol"},{"key":"B22","doi-asserted-by":"publisher","DOI":"10.3389\/fcvm.2021.644035","article-title":"Association between triglyceride-glucose index and hypertension: a meta-analysis","volume":"8","author":"Wang","year":"2021","journal-title":"Front Cardiovasc Med"},{"key":"B23","doi-asserted-by":"publisher","DOI":"10.3389\/fcvm.2025.1597112","article-title":"Research status of triglyceride glucose-body mass index (TyG-BMI index)","volume":"12","author":"Song","year":"2025","journal-title":"Front Cardiovasc Med"},{"key":"B24","doi-asserted-by":"publisher","DOI":"10.1111\/1753-0407.70014","article-title":"Overview of oxidative stress and inflammation in diabetes","volume":"16","author":"Weinberg Sibony","year":"2024","journal-title":"J Diabetes"},{"key":"B25","doi-asserted-by":"publisher","DOI":"10.1002\/hep.24001","article-title":"Evolution of inflammation in nonalcoholic fatty liver disease: the multiple parallel hits hypothesis","volume":"52","author":"Tilg","year":"2010","journal-title":"Hepatology"},{"key":"B26","doi-asserted-by":"publisher","DOI":"10.1016\/j.metabol.2015.12.012","article-title":"The multiple-hit pathogenesis of non-alcoholic fatty liver disease (NAFLD)","volume":"65","author":"Buzzetti","year":"2016","journal-title":"Metabolism"},{"key":"B27","doi-asserted-by":"publisher","first-page":"589","DOI":"10.1016\/j.jhep.2016.05.013","article-title":"Non-alcoholic fatty liver disease and risk of incident cardiovascular disease: a meta-analysis","volume":"65","author":"Targher","year":"2016","journal-title":"J Hepatol"},{"key":"B28","doi-asserted-by":"publisher","first-page":"1237","DOI":"10.3390\/biology11081237","article-title":"Adipokines in non-alcoholic fatty liver disease: are we on the road toward new biomarkers and therapeutic targets","volume":"11","author":"Francisco","year":"2022","journal-title":"Biol (Basel)"},{"key":"B29","doi-asserted-by":"publisher","DOI":"10.1161\/HYPERTENSIONAHA.119.13419","article-title":"Nonalcoholic fatty liver disease: an emerging driver of hypertension","volume":"75","author":"Zhao","year":"2019","journal-title":"Hypertension"},{"key":"B30","doi-asserted-by":"publisher","DOI":"10.1016\/j.jhep.2016.04.005","article-title":"Non-alcoholic fatty liver disease and cardiovascular risk: pathophysiological mechanisms and implications","volume":"65","author":"Francque","year":"2016","journal-title":"J Hepatol"},{"key":"B31","doi-asserted-by":"publisher","DOI":"10.1530\/JOE-13-0201","article-title":"Inflammation as a potential link between nonalcoholic fatty liver disease and insulin resistance","volume":"218","author":"Asrih","year":"2013","journal-title":"J Endocrinol"},{"key":"B32","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCRESAHA.121.318093","article-title":"Obesity, adipose tissue and vascular dysfunction","volume":"128","author":"Koenen","year":"2021","journal-title":"Circ Res"},{"key":"B33","doi-asserted-by":"publisher","DOI":"10.1038\/ajh.2010.144","article-title":"Increased arterial stiffness and impaired endothelial function in nonalcoholic fatty liver disease: a pilot study","volume":"23","author":"Vlachopoulos","year":"2010","journal-title":"Am J Hypertens"},{"key":"B34","doi-asserted-by":"publisher","DOI":"10.1161\/ATVBAHA.114.305200","article-title":"Nonalcoholic fatty liver disease and vascular function: cross-sectional analysis in the Framingham heart study","volume":"35","author":"Long","year":"2015","journal-title":"Arterioscler Thromb Vasc Biol"}],"container-title":["Frontiers in Endocrinology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fendo.2026.1826006\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,5,8]],"date-time":"2026-05-08T04:43:31Z","timestamp":1778215411000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fendo.2026.1826006\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5,8]]},"references-count":34,"alternative-id":["10.3389\/fendo.2026.1826006"],"URL":"https:\/\/doi.org\/10.3389\/fendo.2026.1826006","relation":{},"ISSN":["1664-2392"],"issn-type":[{"value":"1664-2392","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,5,8]]},"article-number":"1826006"}}